AURORA CANNABIS INC current report, Q4 FY2023

Aurora Cannabis Inc. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K, filed on February 8, 2024, by Aurora Cannabis Inc., a foreign private issuer, incorporates by reference the Condensed Consolidated Interim Financial Statements and Interim Management's Discussion and Analysis for the three and nine months ended December 31, 2023, and the comparable periods in 2022.

Key Financial Metrics

The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached exhibits (99.1 and 99.2) which are referenced but not included in the source text.

Material Changes

The filing text does not provide specific details regarding material changes versus prior periods. The document serves as a cover sheet to submit the interim financial statements and management discussion for the periods ended December 31, 2023, and 2022.

Guidance, Outlook, and Risks

The filing text does not include specific guidance, outlook, management commentary, risks, contingencies, or unusual items. Such information is expected to be detailed in the attached Interim Management's Discussion and Analysis (Exhibit 99.2).

Investor Verification Checklist

  • Review Exhibit 99.1 for specific revenue, net loss, and cash flow figures for the three and nine months ended December 31, 2023.
  • Examine Exhibit 99.2 for management's explanation of financial performance and any material changes from 2022.
  • Verify the company's liquidity position and debt obligations as detailed in the attached financial statements.
  • Check for any updated forward-looking statements or risk factors in the Management's Discussion and Analysis.